# US 2017/0283843 A1 · Carbohydrate Binding Module Variants And Polynucleotides Encoding Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0283843 A1
- Document ID: US20170283843A1
- Status: Published application
- Kind: A1
- Application number: 15/508,631
- Filed: 2015-09-04
- Published: 2017-10-05
- Earliest claimed: 2014-09-05
- Assignees: Novozymes A/S
- Applicants: Novozymes A/S
- Inventors: Peter Westh; Kim Borch; Trine Soerensen; Michael Windahl; Brett McBrayer
- Web page: https://patentgrep.com/patent/US20170283843A1

## CPC

- C12P 19/14: produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase}
- C12N 9/2437: {Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)}
- C12N 15/8257: {for the production of primary gene products, e.g. pharmaceutical products, interferon}
- C12P 5/02: acyclic {(C12P5/007 takes precedence)}
- C12P 7/14: Multiple stages of fermentation; Multiple types of microorganisms or re-use of microorganisms
- C12P 7/16: Butanols
- C12P 7/18: polyhydric
- C12P 7/20: Glycerol
- C12P 19/02: Monosaccharides (2-ketogulonic acid C12P7/60)
- C12Y 302/01091: Cellulose 1,4-beta-cellobiosidase (3.2.1.91)
- C07K 2319/00: Fusion polypeptide
- C12P 2203/00: Fermentation products obtained from optionally pretreated or hydrolyzed cellulosic or lignocellulosic material as the carbon source
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention relates to cellobiohydrolase variants and carbohydrate binding module variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.

## Claims

### Claim 1

A cellobiohydrolase variant comprising a substitution at one or more positions corresponding to positions 483, 491, 509 and 510 of SEQ ID NO: 2, wherein the variant has cellobiohydrolase activity.

### Claim 2 (depends on 1)

The variant of claim 1, which is a variant of a parent cellobiohydrolase selected from: (a) a polypeptide having at least 60% sequence identity to the mature polypeptide of SEQ ID NO: 2, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 14, SEQ ID NO: 18, SEQ ID NO: 22, SEQ ID NO: 26, SEQ ID NO: 42, SEQ ID NO: 44, or SEQ ID NO: 78; (b) a polypeptide encoded by a polynucleotide that hybridizes under at least low stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 1, SEQ ID NO: 5, SEQ ID NO: 9, SEQ ID NO: 13, SEQ ID NO: 17, SEQ ID NO: 21, SEQ ID NO: 25, SEQ ID NO: 41, SEQ ID NO: 43, or SEQ ID NO: 77, (ii) the genomic DNA or cDNA sequence thereof, or (iii) the full-length complement of (i) or (ii); (c) a polypeptide encoded by a polynucleotide having at least 60% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 1, SEQ ID NO: 5, SEQ ID NO: 9, SEQ ID NO: 13, SEQ ID NO: 17, SEQ ID NO: 21, SEQ ID NO: 25, SEQ ID NO: 41, SEQ ID NO: 43, or SEQ ID NO: 77; and (d) a fragment of (a), (b), or (c), which has cellobiohydrolase activity.

### Claim 3 (depends on 1)

The variant of claim 1, which has at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100%, sequence identity to the mature polypeptide of SEQ ID NO: 2, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 14, SEQ ID NO: 18, SEQ ID NO: 22, SEQ ID NO: 26, SEQ ID NO: 42, SEQ ID NO: 44, or SEQ ID NO: 78.

### Claim 4 (depends on 1)

The variant of claim 1, which comprises a substitution at a position corresponding to position 483, such as a substitution with Tyr, Phe, or Trp.

### Claim 5 (depends on 1)

The variant of claim 1, which comprises a substitution at a position corresponding to position 491, such as a substitution with Tyr, Phe, or Trp.

### Claim 6 (depends on 1)

The variant of claim 1, which comprises a substitution at a position corresponding to position 509, such as substitution is with Tyr, Phe, or Trp.

### Claim 7 (depends on 1)

The variant of claim 1, which comprises a substitution at a position corresponding to position 510, such as a substitution is with Tyr, Phe, or Trp.

### Claim 8 (depends on 1)

The variant of claim 1, comprising or consisting of SEQ ID NO: 90 or SEQ ID NO: 92, or the mature polypeptide sequence thereof.

### Claim 9

A hybrid polypeptide having cellulolytic activity, comprising:
(a) a fragment at the N-terminal end of the hybrid polypeptide comprising a heterologous catalytic domain of a cellulolytic enzyme; and
(b) a fragment at the C-terminal end of the first polypeptide fragment comprising a carbohydrate binding module (CBM) variant,
wherein the CBM variant comprises a substitution at one or more positions corresponding to positions 5, 13, 31 and 32 of SEQ ID NO: 4.

### Claim 10 (depends on 9)

The hybrid polypeptide of claim 9, wherein the CBM variant is a variant of a parent carbohydrate binding module selected from: (a) a carbohydrate binding module having at least 60% sequence identity to the carbohydrate binding module of SEQ ID NO: 4, SEQ ID NO: 8, SEQ ID NO: 12, SEQ ID NO: 16, SEQ ID NO: 20, SEQ ID NO: 24, or SEQ ID NO: 28; (b) a carbohydrate binding module encoded by a polynucleotide that hybridizes under at least low stringency conditions with the carbohydrate binding module coding sequence of SEQ ID NO: 3, SEQ ID NO: 7, SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 19, SEQ ID NO: 23, or SEQ ID NO: 27, or the full-length complement thereof; (c) a carbohydrate binding module encoded by a polynucleotide having at least 60% sequence identity to the carbohydrate binding module coding sequence of SEQ ID NO: 3, SEQ ID NO: 7, SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 19, SEQ ID NO: 23, or SEQ ID NO: 27.

### Claim 11 (depends on 9)

The hybrid polypeptide of claim 9, wherein the CBM variant has at least 60%, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 81%, at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100%, sequence identity to SEQ ID NO: 4, SEQ ID NO: 8, SEQ ID NO: 12, SEQ ID NO: 16, SEQ ID NO: 20, SEQ ID NO: 24, or SEQ ID NO: 28.

### Claim 12 (depends on 9)

The hybrid polypeptide of claim 9, wherein the CBM variant comprises a substitution at the position corresponding to position 5 of SEQ ID NO: 4, such as a substitution with Tyr, Phe, or Trp.

### Claim 13 (depends on 9)

The hybrid polypeptide of claim 9, wherein the CBM variant comprises a substitution at the position corresponding to position 13 of SEQ ID NO: 4, such as a substitution with Tyr, Phe, or Trp.

### Claim 14 (depends on 9)

The hybrid polypeptide of claim 9, wherein the CBM variant comprises a substitution at the position corresponding to position 31 of SEQ ID NO: 4, such as a substitution with Tyr, Phe, or Trp.

### Claim 15 (depends on 9)

The hybrid polypeptide of claim 9, wherein the CBM variant comprises a substitution at a position corresponding to position 32 of SEQ ID NO: 4, such as a substitution with Tyr, Phe, or Trp.

### Claim 16 (depends on 9)

The hybrid polypeptide of claim 9, comprising or consisting of SEQ ID NO: 61, SEQ ID NO: 63, SEQ ID NO: 73, or SEQ ID NO: 94, or the mature polypeptide thereof.

### Claim 17

A composition comprising a cellobiohydrolase variant comprising a substitution at one or more positions corresponding to positions 483, 491, 509 and 510 of SEQ ID NO: 2, wherein the variant has cellobiohydrolase activity, or a hybrid polypeptide having cellulolytic activity, comprising: (a) a fragment at the N-terminal end of the hybrid polypeptide comprising a heterologous catalytic domain of a cellulolytic enzyme; and (b) a fragment at the C-terminal end of the first polypeptide fragment comprising a carbohydrate binding module (CBM) variant, wherein the CBM variant comprises a substitution at one or more positions corresponding to positions 5, 13, 31 and 32 of SEQ ID NO: 4.

### Claim 18

An isolated polynucleotide encoding a cellobiohydrolase variant comprising a substitution at one or more positions corresponding to positions 483, 491, 509 and 510 of SEQ ID NO: 2, wherein the variant has cellobiohydrolase activity, or a hybrid polypeptide having cellulolytic activity, comprising: (a) a fragment at the N-terminal end of the hybrid polypeptide comprising a heterologous catalytic domain of a cellulolytic enzyme; and (b) a fragment at the C-terminal end of the first polypeptide fragment comprising a carbohydrate binding module (CBM) variant, wherein the CBM variant comprises a substitution at one or more positions corresponding to positions 5, 13, 31 and 32 of SEQ ID NO: 4.

### Claim 19 (depends on 18)

A nucleic acid construct or expression vector comprising the polynucleotide of claim 18.

### Claim 20 (depends on 18)

A host cell comprising the polynucleotide of claim 18.

### Claim 21 (depends on 20)

A method of producing a cellobiohydrolase variant or a hybrid polypeptide, comprising cultivating the host cell of claim 20 under conditions suitable for expression of the cellobiohydrolase variant or the hybrid polypeptide.

### Claim 22 (depends on 18)

A transgenic plant, plant part or plant cell transformed with the polynucleotide of claim 18.

### Claim 23 (depends on 22)

A method of producing a cellobiohydrolase variant or a hybrid polypeptide, comprising: cultivating the transgenic plant, plant part or plant cell of claim 22 under conditions conducive for production of the cellobiohydrolase variant or hybrid polypeptide.

### Claim 24

A method for degrading or converting a cellulosic material, said method comprising: treating the cellulosic material with an enzyme composition, wherein the composition comprises a cellobiohydrolase variant comprising a substitution at one or more positions corresponding to positions 483, 491, 509 and 510 of SEQ ID NO: 2, wherein the variant has cellobiohydrolase activity, or a hybrid polypeptide having cellulolytic activity, comprising: (a) a fragment at the N-terminal end of the hybrid polypeptide comprising a heterologous catalytic domain of a cellulolytic enzyme; and (b) a fragment at the C-terminal end of the first polypeptide fragment comprising a carbohydrate binding module (CBM) variant, wherein the CBM variant comprises a substitution at one or more positions corresponding to positions 5, 13, 31 and 32 of SEQ ID NO: 4.

### Claim 25

A method for producing a fermentation product, said method comprising: (a) saccharifying a cellulosic material with an enzyme composition, wherein the composition a cellobiohydrolase variant comprising a substitution at one or more positions corresponding to positions 483, 491, 509 and 510 of SEQ ID NO: 2, wherein the variant has cellobiohydrolase activity, or a hybrid polypeptide having cellulolytic activity, comprising: (a) a fragment at the N-terminal end of the hybrid polypeptide comprising a heterologous catalytic domain of a cellulolytic enzyme; and (b) a fragment at the C-terminal end of the first polypeptide fragment comprising a carbohydrate binding module (CBM) variant, wherein the CBM variant comprises a substitution at one or more positions corresponding to positions 5, 13, 31 and 32 of SEQ ID NO: 4; and (b) fermenting the saccharified cellulosic material with one or more fermenting microorganisms to produce the fermentation product.
